Tashkent, Uzbekistan (UzDaily.com) — Abdulla Azizov, Director of Uzbekistan’s Pharmaceutical Industry Development Agency, met with representatives of AIYMAN, a company based in Dubai, UAE.

During the meeting, Azizov presented the Tashkent Pharma Park — an innovative pharmaceutical science and production cluster — highlighting ongoing projects and the benefits available to local and foreign manufacturers.

AIYMAN expressed its intention to produce diagnostic tests based on patients' blood plasma to detect hepatitis antibodies and antigens. The parties discussed the legal framework for the project.

As a result, both sides agreed to continue exchanging information and developing mutually beneficial cooperation.